CCA
CRSP icon

Cadent Capital Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Cadent Capital Advisors’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,315
Closed -$699K – 133
2021
Q2 		$699K Buy
+4,315
New +$699K 0.29% 54